{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T16:32:43Z","timestamp":1787243563123,"version":"build-2736575974"},"reference-count":119,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T00:00:00Z","timestamp":1770854400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 82474374"],"award-info":[{"award-number":["No. 82474374"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>\n                    Prostate-related diseases, including prostatitis, benign prostatic hyperplasia (BPH), and prostate cancer (PCa), represent significant threats to the health of the aging male population worldwide. Despite their prevalence, the pathogenesis of prostate-related diseases has not been elucidated. Recent studies have shown that N\n                    <jats:sup>6<\/jats:sup>\n                    -methyladenosine (m\n                    <jats:sup>6<\/jats:sup>\n                    A) modification is widely involved in the progression of prostate-related diseases. In this review, we summarized recent advances in understanding the core m\n                    <jats:sup>6<\/jats:sup>\n                    A regulatory machinery comprising writers such as the methyltransferase-like 3 (METTL3)-METTL14 complex, erasers including fat mass and obesity-associated protein (FTO) and AlkB homolog 5 (ALKBH5), and readers, including the YTH domain-containing family proteins (YTHDFs), YTHDC proteins, insulin-like growth factor 2 mRNA-binding proteins (IGF2BPs), and heterogeneous nuclear ribonucleoproteins (HNRNPs). Specifically, we elucidated how dysregulation of these components drives disease progression via alterations in cellular proliferation, differentiation, inflammatory responses, and stem cell dynamics. Notably, m\n                    <jats:sup>6<\/jats:sup>\n                    A modifications help shape the immunosuppressive landscape in PCa by modulating immune checkpoint expression, cytokine networks, and immune cell infiltration, thereby critically influencing therapeutic responses to immunotherapy. Furthermore, this review highlights the emerging diagnostic potential and therapeutic viability of m\n                    <jats:sup>6<\/jats:sup>\n                    A-targeted strategies, offering valuable insights for future clinical translation in prostate-related diseases.\n                  <\/jats:p>","DOI":"10.3389\/fimmu.2026.1685015","type":"journal-article","created":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T06:46:51Z","timestamp":1770878811000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["The emerging role of m6A methylation in prostate-related diseases: mechanisms and clinical implications"],"prefix":"10.3389","volume":"17","author":[{"given":"Qinghua","family":"Xie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongqi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinghua","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danping","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinrong","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,2,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1002\/pros.23766","article-title":"A randomized, double-blind, placebo-controlled trial to evaluate the role of curcumin in prostate cancer patients with intermittent androgen deprivation","volume":"79","author":"Choi","year":"2019","journal-title":"Prostate"},{"key":"B2","doi-asserted-by":"publisher","first-page":"106106","DOI":"10.1016\/j.ijantimicag.2020.106106","article-title":"Fosfomycin for bacterial prostatitis: a review","volume":"56","author":"Kwan","year":"2020","journal-title":"Int J antimicrobial agents"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3238\/arztebl.2020.0843","article-title":"Current treatment for benign prostatic hyperplasia","volume":"117","author":"Miernik","year":"2020","journal-title":"Deutsches Arzteblatt Int"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.3390\/antiox11061149","article-title":"Origanum majorana L. Extract attenuated benign prostatic hyperplasia in rat model: effect on oxidative stress, apoptosis, and proliferation","volume":"11","author":"Elsherbini","year":"2022","journal-title":"Antioxidants (Basel Switzerland)"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1007\/s00345-019-02719-5","article-title":"Smarter screening for prostate cancer","volume":"37","author":"Tan","year":"2019","journal-title":"World J urol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00950-8","article-title":"Prostate cancer","volume":"398","author":"Sandhu","year":"2021","journal-title":"Lancet (London England)"},{"key":"B7","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3322\/caac.21763","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA: Cancer J Clin"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.21726","article-title":"The M6A methyltransferase METTL3: acting as a tumor suppressor in renal cell carcinoma","volume":"8","author":"Li","year":"2017","journal-title":"Oncotarget"},{"key":"B9","doi-asserted-by":"publisher","first-page":"BSR20192892","DOI":"10.1042\/BSR20192892","article-title":"m6A RNA methylation regulators can contribute to Malignant progression and impact the prognosis of bladder cancer","volume":"39","author":"Chen","year":"2019","journal-title":"Biosci Rep"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.914692","article-title":"Molecular characterization and clinical relevance of N(6)-methyladenosine regulators in metastatic prostate cancer","volume":"12","author":"Liu","year":"2022","journal-title":"Front Oncol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12943-022-01500-4","article-title":"The role of m6A RNA methylation in cancer metabolism","volume":"21","author":"An","year":"2022","journal-title":"Mol can"},{"key":"B12","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1186\/s12943-022-01680-z","article-title":"Biological and pharmacological roles of m(6)A modifications in cancer drug resistance","volume":"21","author":"Liu","year":"2022","journal-title":"Mol can"},{"key":"B13","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s12943-022-01510-2","article-title":"m6A modification: recent advances, anticancer targeted drug discovery and beyond","volume":"21","author":"Deng","year":"2022","journal-title":"Mol can"},{"key":"B14","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s12943-021-01362-2","article-title":"Comprehensive analyses of m6A regulators and interactive coding and non-coding RNAs across 32 cancer types","volume":"20","author":"Shen","year":"2021","journal-title":"Mol can"},{"key":"B15","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/s41420-022-01003-7","article-title":"N6-methyladenosine demethylase FTO suppressed prostate cancer progression by maintaining CLIC4 mRNA stability","volume":"8","author":"Zou","year":"2022","journal-title":"Cell Death discov"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-025-02128-y","article-title":"The landscape of N(6)-methyladenosine in localized primary prostate cancer","volume":"57","author":"Xu","year":"2025","journal-title":"Nat Genet"},{"key":"B17","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1186\/s12943-020-01267-6","article-title":"YTHDF2 mediates the mRNA degradation of the tumor suppressors to induce AKT phosphorylation in N6-methyladenosine-dependent way in prostate cancer","volume":"19","author":"Li","year":"2020","journal-title":"Mol can"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2023.01.006","article-title":"RNA m6A methylation across the transcriptome","volume":"83","author":"Sendinc","year":"2023","journal-title":"Mol Cell"},{"key":"B19","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1261\/rna.064063.117","article-title":"Interactions, localization, and phosphorylation of the m(6)A generating METTL3-METTL14-WTAP complex","volume":"24","author":"Sch\u00f6ller","year":"2018","journal-title":"RNA (New York NY)"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1101\/gad.309146.117","article-title":"Zc3h13\/Flacc is required for adenosine methylation by bridging the mRNA-binding factor Rbm15\/Spenito to the m(6)A machinery component Wtap\/Fl(2)d","volume":"32","author":"Knuckles","year":"2018","journal-title":"Genes Dev"},{"key":"B21","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41392-020-00450-x","article-title":"The role of m6A modification in the biological functions and diseases","volume":"6","author":"Jiang","year":"2021","journal-title":"Signal transduct targeted Ther"},{"key":"B22","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/j.cell.2017.05.003","article-title":"The U6 snRNA m(6)A Methyltransferase METTL16 Regulates SAM Synthetase Intron Retention","volume":"169","author":"Pendleton","year":"2017","journal-title":"Cell"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1038\/nature19342","article-title":"m(6)A RNA methylation promotes XIST-mediated transcriptional repression","volume":"537","author":"Patil","year":"2016","journal-title":"Nature"},{"key":"B24","doi-asserted-by":"publisher","first-page":"e18434","DOI":"10.7554\/eLife.18434","article-title":"Structural insights into the molecular mechanism of the m(6)A writer complex","volume":"5","author":"\u015aled\u017a","year":"2016","journal-title":"eLife"},{"key":"B25","doi-asserted-by":"publisher","first-page":"771","DOI":"10.3390\/cancers12040771","article-title":"VIRMA-dependent N6-methyladenosine modifications regulate the expression of long non-coding RNAs CCAT1 and CCAT2 in prostate cancer","volume":"12","author":"Barros-Silva","year":"2020","journal-title":"Cancers"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.R115.656462","article-title":"The alkB family of fe(II)\/\u03b1-ketoglutarate-dependent dioxygenases: repairing nucleic acid alkylation damage and beyond","volume":"290","author":"Fedeles","year":"2015","journal-title":"J Biol Chem"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1617467114","article-title":"Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing","volume":"114","author":"Fei","year":"2017","journal-title":"Proc Natl Acad Sci United States Am"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1038\/cr.2017.10","article-title":"Cytoplasmic m(6)A reader YTHDF3 promotes mRNA translation","volume":"27","author":"Li","year":"2017","journal-title":"Cell Res"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.24272\/j.issn.2095-8137.2024.399","article-title":"Single-cell sequencing analysis reveals the essential role of the m (6)A reader YTHDF1 in retinal visual function by regulating TULP1 and DHX38 translation","volume":"46","author":"Zhu","year":"2025","journal-title":"Zoologic Res"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1038\/cr.2017.15","article-title":"YTHDF3 facilitates translation and decay of N(6)-methyladenosine-modified RNA","volume":"27","author":"Shi","year":"2017","journal-title":"Cell Res"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2020.592042","article-title":"YTHDF2 inhibits gastric cancer cell growth by regulating FOXC2 signaling pathway","volume":"11","author":"Shen","year":"2020","journal-title":"Front Genet"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1021\/acschembio.2c00131","article-title":"YTHDF3 Facilitates eIF2AK2 and eIF3A Recruitment on mRNAs to Regulate Translational Processes in Oxaliplatin-Resistant Colorectal Cancer","volume":"17","author":"Zhao","year":"2022","journal-title":"ACS Chem Biol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2021.07.012","article-title":"UHRF1 promotes androgen receptor-regulated CDC6 transcription and anti-androgen receptor drug resistance in prostate cancer through KDM4C-Mediated chromatin modifications","volume":"520","author":"Gao","year":"2021","journal-title":"Cancer lett"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.58514","article-title":"Downregulation of m(6)A Reader YTHDC2 Promotes the Proliferation and Migration of Malignant Lung Cells via CYLD\/NF-\u03baB Pathway","volume":"17","author":"Wang","year":"2021","journal-title":"Int J Biol Sci"},{"key":"B35","doi-asserted-by":"publisher","first-page":"217426","DOI":"10.1016\/j.canlet.2024.217426","article-title":"Histone lactylation-driven YTHDC1 promotes hepatocellular carcinoma progression via lipid metabolism remodeling","volume":"611","author":"Du","year":"2024","journal-title":"Cancer lett"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.7150\/thno.100703","article-title":"The m6A reader YTHDC2 promotes the pathophysiology of temporal lobe epilepsy by modulating SLC7A11-dependent glutamate dysregulation in astrocytes","volume":"14","author":"Zhang","year":"2024","journal-title":"Theranostics"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2015.08.011","article-title":"HNRNPA2B1 is a mediator of m(6)A-dependent nuclear RNA processing events","volume":"162","author":"Alarc\u00f3n","year":"2015","journal-title":"Cell"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-012-1186-z","article-title":"Insulin-like growth factor 2 mRNA-binding proteins (IGF2BPs): post-transcriptional drivers of cancer progression","volume":"70","author":"Bell","year":"2013","journal-title":"Cell Mol Life sci: CMLS"},{"key":"B39","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/j.gendis.2023.06.017","article-title":"IGF2BPs as novel m(6)A readers: Diverse roles in regulating cancer cell biological functions, hypoxia adaptation, metabolism, and immunosuppressive tumor microenvironment","volume":"11","author":"Duan","year":"2024","journal-title":"Genes dis"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1021\/acscentsci.2c00107","article-title":"Allosteric regulation of IGF2BP1 as a novel strategy for the activation of tumor immune microenvironment","volume":"8","author":"Liu","year":"2022","journal-title":"ACS Cent sci"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2018.06.034","article-title":"The function and clinical significance of eIF3 in cancer","volume":"673","author":"Yin","year":"2018","journal-title":"Gene"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.tibs.2006.08.005","article-title":"eIF3: a versatile scaffold for translation initiation complexes","volume":"31","author":"Hinnebusch","year":"2006","journal-title":"Trends Biochem Sci"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2011.06.013","article-title":"FMRP stalls ribosomal translocation on mRNAs linked to synaptic function and autism","volume":"146","author":"Darnell","year":"2011","journal-title":"Cell"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/j.cub.2004.09.085","article-title":"The Drosophila fragile X gene negatively regulates neuronal elaboration and synaptic differentiation","volume":"14","author":"Pan","year":"2004","journal-title":"Curr biol: CB"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1038\/s41467-023-37252-y","article-title":"The m6A reader PRRC2A is essential for meiosis I completion during spermatogenesis","volume":"14","author":"Tan","year":"2023","journal-title":"Nat Commun"},{"key":"B46","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/s41422-018-0113-8","article-title":"A novel m(6)A reader Prrc2a controls oligodendroglial specification and myelination","volume":"29","author":"Wu","year":"2019","journal-title":"Cell Res"},{"key":"B47","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s12943-023-01810-1","article-title":"Epigenetic modification of m(6)A regulator proteins in cancer","volume":"22","author":"Wang","year":"2023","journal-title":"Mol can"},{"key":"B48","doi-asserted-by":"publisher","first-page":"e0275064","DOI":"10.1371\/journal.pone.0275064","article-title":"The IL-4\/IL-13 signaling axis promotes prostatic fibrosis","volume":"17","author":"D\u2019Arcy","year":"2022","journal-title":"PloS One"},{"key":"B49","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1007\/s00018-025-05608-w","article-title":"Irf7 aggravates prostatitis by promoting Hif-1\u03b1-mediated glycolysis to facilitate M1 polarization","volume":"82","author":"Meng","year":"2025","journal-title":"Cell Mol Life sci: CMLS"},{"key":"B50","doi-asserted-by":"publisher","first-page":"e177932","DOI":"10.1172\/JCI177932","article-title":"Elevated WTAP promotes hyperinflammation by increasing m6A modification in inflammatory disease models","volume":"134","author":"Ge","year":"2024","journal-title":"J Clin Invest"},{"key":"B51","doi-asserted-by":"publisher","first-page":"2400308","DOI":"10.1002\/smsc.202400308","article-title":"m6A ribonucleic acid methylation in fibrotic diseases of visceral organs","volume":"5","author":"Dai","year":"2025","journal-title":"Small sci"},{"key":"B52","doi-asserted-by":"publisher","first-page":"eado5266","DOI":"10.1126\/scitranslmed.ado5266","article-title":"Inhibiting endothelial Rhoj blocks profibrotic vascular intussusception and angiocrine factors to sustain lung regeneration","volume":"16","author":"Ma","year":"2024","journal-title":"Sci Trans Med"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2022.07.020","article-title":"The m(6)A methyltransferase Mettl3 deficiency attenuates hepatic stellate cell activation and liver fibrosis","volume":"30","author":"Li","year":"2022","journal-title":"Mol ther: J Am Soc Gene Ther"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2024.1380746","article-title":"The functions and mechanisms of RNA modification in prostate: Current status and future perspectives","volume":"15","author":"Zhang","year":"2024","journal-title":"Front Genet"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1111\/cas.15745","article-title":"HNRNPC suppresses tumor immune microenvironment by activating Treg cells promoting the progression of prostate cancer","volume":"114","author":"Cheng","year":"2023","journal-title":"Cancer sci"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.18632\/aging.204679","article-title":"Insights into N6-methyladenosine (m6A) modification of noncoding RNA in tumor microenvironment","volume":"15","author":"Zhang","year":"2023","journal-title":"Aging"},{"key":"B57","doi-asserted-by":"publisher","first-page":"e2412123","DOI":"10.1002\/advs.202412123","article-title":"METTL3 potentiates M2 macrophage-driven MMT to aggravate renal allograft fibrosis via the TGF-\u03b21\/smad3 pathway","volume":"12","author":"Yao","year":"2025","journal-title":"Adv Sci (Weinheim Baden-Wurttemberg Germany)"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1111\/bju.15229","article-title":"Benign prostatic hyperplasia - what do we know","volume":"127","author":"Devlin","year":"2021","journal-title":"BJU Int"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1002\/pros.21138","article-title":"Antiproliferative and apoptotic effects of the herbal agent Pygeum africanum on cultured prostate stromal cells from patients with benign prostatic hyperplasia (BPH)","volume":"70","author":"Quiles","year":"2010","journal-title":"Prostate"},{"key":"B60","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1038\/s41467-020-15913-6","article-title":"Integrative multiplatform molecular profiling of benign prostatic hyperplasia identifies distinct subtypes","volume":"11","author":"Liu","year":"2020","journal-title":"Nat Commun"},{"key":"B61","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1038\/s41419-022-05162-4","article-title":"METTL3 promotes prostatic hyperplasia by regulating PTEN expression in an m(6)A-YTHDF2-dependent manner","volume":"13","author":"Li","year":"2022","journal-title":"Cell Death dis"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1021\/acs.analchem.9b04505","article-title":"YTHDF2 binds to 5-methylcytosine in RNA and modulates the maturation of ribosomal RNA","volume":"92","author":"Dai","year":"2020","journal-title":"Analytic Chem"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1038\/nature02006","article-title":"Smad-dependent and Smad-independent pathways in TGF-beta family signalling","volume":"425","author":"Derynck","year":"2003","journal-title":"Nature"},{"key":"B64","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s13045-022-01231-5","article-title":"Functions, mechanisms, and therapeutic implications of METTL14 in human cancer","volume":"15","author":"Guan","year":"2022","journal-title":"J Hematol Oncol"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.18632\/aging.203541","article-title":"METTL3-mediated m6A modification of KIF3C-mRNA promotes prostate cancer progression and is negatively regulated by miR-320d","volume":"13","author":"Ma","year":"2021","journal-title":"Aging"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.7150\/jca.42338","article-title":"The M6A methyltransferase METTL3 promotes the development and progression of prostate carcinoma via mediating MYC methylation","volume":"11","author":"Yuan","year":"2020","journal-title":"J Can"},{"key":"B67","doi-asserted-by":"publisher","first-page":"117366","DOI":"10.1016\/j.biopha.2024.117366","article-title":"METTL3 inhibitor suppresses the progression of prostate cancer via IGFBP3\/AKT pathway and synergizes with PARP inhibitor","volume":"179","author":"Chen","year":"2024","journal-title":"Biomed pharmacother = Biomed pharmacother"},{"key":"B68","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/s41420-022-00939-0","article-title":"METTL14 promotes prostate tumorigenesis by inhibiting THBS1 via an m6A-YTHDF2-dependent mechanism","volume":"8","author":"Wang","year":"2022","journal-title":"Cell Death discov"},{"key":"B69","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/s41467-024-55694-w","article-title":"Divergent roles of m(6)A in orchestrating brown and white adipocyte transcriptomes and systemic metabolism","volume":"16","author":"Xiao","year":"2025","journal-title":"Nat Commun"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2021.845413","article-title":"Corrigendum: RNA m6A methylation regulators multi-omics analysis in prostate cancer","volume":"12","author":"Su","year":"2021","journal-title":"Front Genet"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1448872","article-title":"The m(6)A regulators in prostate cancer: molecular basis and clinical perspective","volume":"15","author":"Cao","year":"2024","journal-title":"Front Pharmacol"},{"key":"B72","doi-asserted-by":"publisher","first-page":"119180","DOI":"10.1016\/j.lfs.2021.119180","article-title":"The FTO m(6)A demethylase inhibits the invasion and migration of prostate cancer cells by regulating total m(6)A levels","volume":"271","author":"Zhu","year":"2021","journal-title":"Life Sci"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1080\/21655979.2021.2001936","article-title":"Demethyltransferase FTO alpha-ketoglutarate dependent dioxygenase (FTO) regulates the proliferation, migration, invasion and tumor growth of prostate cancer by modulating the expression of melanocortin 4 receptor (MC4R)","volume":"13","author":"Li","year":"2022","journal-title":"Bioengineered"},{"key":"B74","doi-asserted-by":"publisher","first-page":"0313","DOI":"10.34133\/research.0313","article-title":"The FTO mediated N6-methyladenosine modification of DDIT4 regulation with tumorigenesis and metastasis in prostate cancer","volume":"7","author":"Zhao","year":"2024","journal-title":"Res (Washington DC)"},{"key":"B75","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1038\/s41420-024-02060-w","article-title":"ZFHX3 acts as a tumor suppressor in prostate cancer by targeting FTO-mediated m(6)A demethylation","volume":"10","author":"Hu","year":"2024","journal-title":"Cell Death discov"},{"key":"B76","doi-asserted-by":"publisher","first-page":"43","DOI":"10.4103\/cjop.CJOP-D-22-00071","article-title":"MiR-141-3p promotes Malignant progression in prostate cancer through AlkB homolog 5-mediated m(6)A modification of protein arginine methyltransferase 6","volume":"66","author":"Li","year":"2023","journal-title":"Chin J Physiol"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1002\/mc.23609","article-title":"USF1-mediated ALKBH5 stabilizes FLII mRNA in an m6A-YTHDF2-dependent manner to repress glycolytic activity in prostate adenocarcinoma","volume":"62","author":"Fu","year":"2023","journal-title":"Mol carcinogen"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2016.01.012","article-title":"Nuclear m(6)A Reader YTHDC1 Regulates mRNA Splicing","volume":"61","author":"Xiao","year":"2016","journal-title":"Mol Cell"},{"key":"B79","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1038\/s41419-025-07648-3","article-title":"YTHDF1\/RNF7\/p27 axis promotes prostate cancer progression","volume":"16","author":"Shi","year":"2025","journal-title":"Cell Death dis"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkab1247","article-title":"Regulation of AR mRNA translation in response to acute AR pathway inhibition","volume":"50","author":"Somasekharan","year":"2022","journal-title":"Nucleic Acids Res"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1038\/s43018-024-00820-2","article-title":"Integrative proteogenomic profiling of high-risk prostate cancer samples from Chinese patients indicates metabolic vulnerabilities and diagnostic biomarkers","volume":"5","author":"Dong","year":"2024","journal-title":"Nat can"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-025-02139-9","article-title":"Spatially resolved transcriptomic analysis of the adult human prostate","volume":"57","author":"Hu","year":"2025","journal-title":"Nat Genet"},{"key":"B83","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1002\/ijc.24744","article-title":"Increased expression of the heterogeneous nuclear ribonucleoprotein K in pancreatic cancer and its association with the mutant p53","volume":"126","author":"Zhou","year":"2010","journal-title":"Int J can"},{"key":"B84","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12935-021-02438-1","article-title":"Construction of a risk prediction model using m6A RNA methylation regulators in prostate cancer: comprehensive bioinformatic analysis and histological validation","volume":"22","author":"Quan","year":"2022","journal-title":"Cancer Cell Int"},{"key":"B85","doi-asserted-by":"publisher","first-page":"e2220190120","DOI":"10.1073\/pnas.2220190120","article-title":"The RNA-binding proteins hnRNP H and F regulate splicing of a MYC-dependent HRAS exon in prostate cancer cells","volume":"120","author":"Chen","year":"2023","journal-title":"Proc Natl Acad Sci United States Am"},{"key":"B86","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1038\/s41420-024-02198-7","article-title":"Regulation of HNRNP family by post-translational modifications in cancer","volume":"10","author":"Li","year":"2024","journal-title":"Cell Death discov"},{"key":"B87","doi-asserted-by":"publisher","first-page":"5086","DOI":"10.3390\/ijms24065086","article-title":"Role of heterogeneous nuclear ribonucleoproteins in the cancer-immune landscape","volume":"24","author":"Sudhakaran","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B88","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1038\/s41580-023-00654-3","article-title":"Publisher Correction: Reading, writing and erasing mRNA methylation","volume":"24","author":"Zaccara","year":"2023","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1038\/s41556-024-01544-2","article-title":"FMRP regulates MFF translation to locally direct mitochondrial fission in neurons","volume":"26","author":"Fenton","year":"2024","journal-title":"Nat Cell Biol"},{"key":"B90","doi-asserted-by":"publisher","first-page":"eabl7207","DOI":"10.1126\/science.abl7207","article-title":"Aberrant hyperexpression of the RNA binding protein FMRP in tumors mediates immune evasion","volume":"378","author":"Zeng","year":"2022","journal-title":"Sci (New York NY)"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1007\/s00345-020-03497-1","article-title":"Immunotherapy in prostate cancer: new horizon of hurdles and hopes","volume":"39","author":"Tsaur","year":"2021","journal-title":"World J urol"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1080\/14712598.2022.2027904","article-title":"Prostate cancer immunotherapy","volume":"22","author":"Mitsogiannis","year":"2022","journal-title":"Expert Opin Biol Ther"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1016\/j.ucl.2020.10.005","article-title":"The tumor microenvironment and immunotherapy in prostate and bladder cancer","volume":"47","author":"Nair","year":"2020","journal-title":"Urologic Clinics North Am"},{"key":"B94","doi-asserted-by":"publisher","first-page":"188961","DOI":"10.1016\/j.bbcan.2023.188961","article-title":"RNA m(6)A modification in prostate cancer: A new weapon for its diagnosis and therapy","volume":"1878","author":"Han","year":"2023","journal-title":"Biochim Biophys Acta Rev can"},{"key":"B95","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1038\/s41467-021-21514-8","article-title":"RNA m6A methylation orchestrates cancer growth and metastasis via macrophage reprogramming","volume":"12","author":"Yin","year":"2021","journal-title":"Nat Commun"},{"key":"B96","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1016\/j.molcel.2022.02.033","article-title":"Lactylation-driven METTL3-mediated RNA m(6)A modification promotes immunosuppression of tumor-infiltrating myeloid cells","volume":"82","author":"Xiong","year":"2022","journal-title":"Mol Cell"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1021\/acsami.2c09978","article-title":"Cyclodextrin-functionalized gold nanorods loaded with meclofenamic acid for improving N(6)-methyladenosine-mediated second near-infrared photothermal immunotherapy","volume":"14","author":"Liu","year":"2022","journal-title":"ACS Appl mat interfaces"},{"key":"B98","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/j.apsb.2021.07.016","article-title":"Abrogation of HnRNP L enhances anti-PD-1 therapy efficacy via diminishing PD-L1 and promoting CD8(+) T cell-mediated ferroptosis in castration-resistant prostate cancer","volume":"12","author":"Zhou","year":"2022","journal-title":"Acta Pharm Sin B"},{"key":"B99","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/j.ccell.2021.04.016","article-title":"The loss of RNA N(6)-adenosine methyltransferase Mettl14 in tumor-associated macrophages promotes CD8(+) T cell dysfunction and tumor growth","volume":"39","author":"Dong","year":"2021","journal-title":"Cancer Cell"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.735170","article-title":"Characterization of the m6A-associated tumor immune microenvironment in prostate cancer to aid immunotherapy","volume":"12","author":"Liu","year":"2021","journal-title":"Front Immunol"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1080\/21691401.2021.1912759","article-title":"Analysis of RNA m(6)A methylation regulators and tumour immune cell infiltration characterization in prostate cancer","volume":"49","author":"Zhao","year":"2021","journal-title":"Artif cells nanomedi Biotechnol"},{"key":"B102","doi-asserted-by":"publisher","first-page":"e195840","DOI":"10.1172\/JCI195840","article-title":"EZH2 crosstalk with RNA methylation promotes prostate cancer progression through modulation of m6A autoregulation pathway","volume":"136","author":"Yi","year":"2025","journal-title":"J Clin Invest"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1007\/s10895-017-2086-2","article-title":"Study of the binding between camptothecin analogs and FTO by spectroscopy and molecular docking","volume":"27","author":"Ren","year":"2017","journal-title":"J fluoresc"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.21037\/tau-24-276","article-title":"Anti-cancer role of curcumin in prostate cancer cells via regulation of m6A-modified circ0030568-FMR1 signaling pathway","volume":"13","author":"Sun","year":"2024","journal-title":"Trans androl urol"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S291865","article-title":"Effects of quercetin on the efficacy of various chemotherapeutic drugs in cervical cancer cells","volume":"15","author":"Xu","year":"2021","journal-title":"Drug design Dev Ther"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1039\/D0FO00565G","article-title":"Prospective randomized trial evaluating blood and prostate tissue concentrations of green tea polyphenols and quercetin in men with prostate cancer","volume":"11","author":"Henning","year":"2020","journal-title":"Food Funct"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1038\/s41585-023-00851-x","article-title":"RNA N(6)-methyladenosine modifications in urological cancers: from mechanism to application","volume":"21","author":"Yang","year":"2024","journal-title":"Nat Rev Urol"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.26355\/eurrev_202004_21006","article-title":"Simvastatin is beneficial to lung cancer progression by inducing METTL3-induced m6A modification on EZH2 mRNA","volume":"24","author":"Chen","year":"2020","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.2019.4774","article-title":"Simvastatin delays castration\u2212resistant prostate cancer metastasis and androgen receptor antagonist resistance by regulating the expression of caveolin\u22121","volume":"54","author":"Gao","year":"2019","journal-title":"Int J Oncol"},{"key":"B110","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1038\/s41420-025-02680-w","article-title":"Emerging implications of N6-methyladenosine in prostate cancer progression and treatment","volume":"11","author":"Xu","year":"2025","journal-title":"Cell Death discov"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.19540\/j.cnki.cjcmm.20240729.501","article-title":"Research progress of traditional Chinese medicine in treatment of benign prostatic hyperplasia","volume":"49","author":"Li","year":"2024","journal-title":"Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China J Chin materia med"},{"key":"B112","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.3390\/cancers16071303","article-title":"RNA m6a methylation regulator expression in castration-resistant prostate cancer progression and its genetic associations","volume":"16","author":"Liyanage","year":"2024","journal-title":"Cancers"},{"key":"B113","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/s41586-021-03536-w","article-title":"Small-molecule inhibition of METTL3 as a strategy against myeloid leukaemia","volume":"593","author":"Yankova","year":"2021","journal-title":"Nature"},{"key":"B114","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.ccell.2019.03.006","article-title":"Small-molecule targeting of oncogenic FTO demethylase in acute myeloid leukemia","volume":"35","author":"Huang","year":"2019","journal-title":"Cancer Cell"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1038\/nrm3785","article-title":"The dynamic epitranscriptome: N6-methyladenosine and gene expression control","volume":"15","author":"Meyer","year":"2014","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B116","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1186\/s12943-019-1109-9","article-title":"Functions of N6-methyladenosine and its role in cancer","volume":"18","author":"He","year":"2019","journal-title":"Mol can"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.4103\/aja202265","article-title":"Research progress of m(6)A methylation in prostate cancer","volume":"25","author":"Zhang","year":"2023","journal-title":"Asian J androl"},{"key":"B118","doi-asserted-by":"publisher","first-page":"e52146","DOI":"10.15252\/embr.202052146","article-title":"Curcumin prevents obesity by targeting TRAF4-induced ubiquitylation in m(6) A-dependent manner","volume":"22","author":"Chen","year":"2021","journal-title":"EMBO Rep"},{"key":"B119","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1038\/s41366-018-0082-5","article-title":"Epigallocatechin gallate targets FTO and inhibits adipogenesis in an mRNA m(6)A-YTHDF2-dependent manner","author":"Wu","year":"2005","journal-title":"Int J Obes"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1685015\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T06:50:53Z","timestamp":1770879053000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1685015\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,12]]},"references-count":119,"alternative-id":["10.3389\/fimmu.2026.1685015"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1685015","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,12]]},"article-number":"1685015"}}